SCHIMMEL PAUL
SEC CIK 1236447 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ATYR | aTYR PHARMA INC | Dir | 779.1K | $3.60M | — | 8 | 2021-09-20 | 2026-05-27 |
Most active insiders at ATYR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | SCHIMMEL PAUL | Dir | $962.3K | — |
| 2 | Shukla Sanjay | Pres, CEO, Dir | — | $3,670 |
| 3 | Broadfoot Jill Marie | CFO | — | $1,527 |
| 4 | DENYES NANCY | GC | — | $1,096 |
Transactions 8
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2026-05-28 16:12 | 2026-05-27 | ATYR | aTYR PHARMA INC | SCHIMMEL PAUL | Dir | P - Purchase | $0.4963 | +100.0K | 779.1K | +15% | +$49.6K |
| MI | 2025-10-09 | 2025-10-08+ | ATYR | aTYR PHARMA INC | SCHIMMEL PAUL | Dir | P - Purchase | $0.9127 | +1.00M | 1.41M | +242% | +$912.7K |
| MI | 2024-07-24 | 2024-07-22+ | ATYR | aTYR PHARMA INC | SCHIMMEL PAUL | Dir | P - Purchase | $1.84 | +100.0K | 413.0K | +32% | +$184.5K |
| I | 2023-05-11 | 2023-05-10 | ATYR | aTYR PHARMA INC | SCHIMMEL PAUL | Dir | P - Purchase | $2.25 | +200.0K | 313.0K | +177% | +$450.0K |
| D | 2023-04-28 | 2023-04-26 | ATYR | aTYR PHARMA INC | SCHIMMEL PAUL | Dir | M - OptEx | — | +6,000 | 8,890 | +208% | — |
| 2021-09-22 | 2021-09-20 | ATYR | aTYR PHARMA INC | SCHIMMEL PAUL | Dir | G - Gift | $0.00 | -250.0K | 2,890 | -99% | $0 | |
| 2021-09-22 | 2021-09-20 | ATYR | aTYR PHARMA INC | SCHIMMEL PAUL | Dir | P - Purchase | $8.00 | +250.0K | 252.9K | +8,651% | +$2.00M | |
| I | 2021-09-22 | 2021-09-20 | ATYR | aTYR PHARMA INC | SCHIMMEL PAUL | Dir | G - Gift | $0.00 | +250.0K | 679.1K | +58% | $0 |
Purchase Sale Sale after option exercise All abbreviations